Genzyme moves to strengthen defenses against Icahn
Genzyme Corp has moved again to strengthen its defenses against billionaire investor Carl Icahn, who is seeking four seats on the biotechnology company's board.
Biogen Idec Inc said on Thursday it has won a proxy fight against billionaire Carl Icahn, who was seeking to place three nominees on the biotechnology company's board.